Nrf2 Overexpression in Pancreatic Cancer and Its Implications
Author Information
Author(s): Lister Adam, Nedjadi Taoufik, Kitteringham Neil R, Campbell Fiona, Costello Eithne, Lloyd Bryony, Copple Ian M, Williams Samantha, Owen Andrew, Neoptolemos John P, Goldring Chris E, Park B Kevin
Primary Institution: University of Liverpool
Hypothesis
The Nrf2/Keap1 system is dysregulated in pancreatic cancer, affecting cell proliferation and response to therapy.
Conclusion
Nrf2 is up-regulated in pancreatic cancer, which may enhance cell proliferation and resistance to chemotherapy.
Supporting Evidence
- Nrf2 expression was significantly higher in pancreatic cancer cells compared to benign cells.
- Depletion of Nrf2 reduced cell proliferation in pancreatic cancer cell lines.
- Nrf2 depletion increased sensitivity to gemcitabine and cisplatin in certain pancreatic cancer cells.
Takeaway
Nrf2 helps pancreatic cancer cells grow and resist treatment, so changing its levels might help make the cancer easier to treat.
Methodology
The study analyzed Nrf2 and Keap1 expression in pancreatic cancer cell lines and tissues, using RNAi and immunohistochemistry.
Limitations
The study did not explore the long-term effects of Nrf2 manipulation in vivo.
Participant Demographics
The study included pancreatic cancer cell lines and human tumor samples.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website